Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07199192 · ClinicalTrials.gov registry record · Phase 4
Steroid Treatment for Severe Acute Respiratory Infection (STAR) Trial
A Phase 4 study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Not yet
- Registry status
- Phase 4
- Development phase
- 3,000
- Enrollment target
NCT07199192 is a Phase 4 study that has not yet begun recruiting, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 3,000 participants.
The verdict
NCT07199192, a Phase 4 study, has not yet begun recruiting, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 3,000 participants
- Enrollment target
Study Summary
Multicenter, parallel-group, randomized clinical trial comparing the administration of systemic corticosteroids at a dose equivalent to 40 mg of prednisolone per day for 7 days vs no corticosteroid administration among adults hospitalized with severe acute respiratory infection and hypoxemia.
Interventions
- DRUG Corticosteroid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2026-03-01 |
| Est. Completion | 2028-12-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07199192
The ClinicalTrials.gov registry entry for NCT07199192 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Corticosteroid is the first listed.
NCT07199192 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07199192 about?
NCT07199192 is a clinical study titled "Steroid Treatment for Severe Acute Respiratory Infection (STAR) Trial". Multicenter, parallel-group, randomized clinical trial comparing the administration of systemic corticosteroids at a dose equivalent to 40 mg of prednisolone per day for 7 days vs no corticosteroid administration among adults hospitalized with severe acute respiratory infection and hypoxemia.
What is the current status of trial NCT07199192?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 3,000 participants. The study started on 2026-03-01. Estimated completion is 2028-12-01.
What interventions are being tested in trial NCT07199192?
The interventions under investigation include: Corticosteroid (DRUG).
Who is sponsoring clinical trial NCT07199192?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.